Relationship between Specific Gravity of Cupric Sulfate and Saturation of Blood Droplets During
A new hypothesis regarding the etiology of preeclampsia has been targeted at the immune response. Cytokines are immunoregulatory substances that may be involved in the pathogenesis of preeclampsia. Type 1 cytokine receptors (interleukin-2), type 2 cytokine receptors(interferon), and type 2 cytokine receptors (tumor necrosis factor alpha-TNFα) are generally produced in an inflammatory process induced by preeclampsia. Several previous types of research even have already shown variations in the levels of cytokines in preeclampsia females although the roles of pathogenesis and expressions in the disease were 4 still controversial.
T h e s o u r c e s o f T N F -α p r o d u c t i o n i n preeclampsia, furthermore, are neutrophils, monocytes, and possibly placenta. One of the possible mechanisms in preeclampsia was that factors derived from the placenta stimulated monocytes and neutrophils to produce TNF-α resulting in endothelial disruption. Therefore, it seemed that increased serum TNF-α might be part of the pathology of preeclampsia. Meanwhile, interleukin-6, usually identified as a B-cell differentiating factor, is a multifunctional cytokine in 4, 5 various tissues and cells.
Interleukin-6 is a pleiotropic cytokine mainly involved in the regulation of inflammation, immune response, and 5, 6 hematopoiesis.
As a result, it can be said that preeclampsia involves a number of maternal, placental, and fetal factors, such as: Adaptation of the placenta with abnormal trophoblasts passing into uterine arteries; The occurrence of maladaptive immunology was in between placenta or paternal, maternal tissue, and fetal tissue; No adaptation between maternal tissue and vascular or inflammatory tissue was found in normal pregnancy; Gene predisposing factors was found in the form of inherited genetic factors along 2 with the presence of epigenetic influences. 
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The diagnosis of preeclampsia using the classic diagnostic triad included recent hypertension (increased systolic blood pressure greater than 140 mmHg or diastolic blood pressure greater than 90 2 mmHg), proteinuria, and edema. Proteinuria was characterized with the presence of 24-hour proteinuria more than 300 mg, the protein to creatinine ratio of ≥ 0.3, or the urine protein dipstick of 1+ (30mg/dL persistent) in random urine The total number of samples in this research was 30 pregnant females with preeclampsia and 30 normal pregnant females as the control group. Those samples had already met inclusion criteria, such as pregnant females diagnosed with preeclampsia, an intrauterine pregnancy, and willing to participate in this research by signing on the research approval sheet. On the other hand, the exclusion criteria in this research were high-risk pregnant patients with DM, kidney disorders, liver disorders, infectious diseases (pneumonia), or acute rheumatic fever. All blood samples then were taken, and IL-6 and TNF-α were examined. Based on Table 1 , the mean level of Interleukin-6 in the subjects with preeclampsia was 48.60±10.85, while the mean level of TNF-α was 79.24±10.43. On the other hand, it was also known that the mean level of interleukin-6 in the subjects with normal pregnant was 31.99±2.65, while the mean level of TNF-α was 61.36±5.04.
RESULTS AND DISCUSSION
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Next, the relationship between interleukin-6 and TNF-αin both of the preeclampsia and control groups was examined using an independent t-test. Results of the independent t-test indicated that there were significant differences in the levels of interleukin-6 and TNF-α in both groups with a p-value of 0.001.
Various theories have already analyzed the etiology and pathogenesis of preeclampsia. Endothelial damage, for instance, is considered as an essential factor found in the final stages of preeclampsia process. If endothelial damage does not occur during preeclampsia, an inflammatory response in the form of an increase in proinflammatory cytokines will accumulate macrophages to the perivascular system, known as atherosis. Cytokines as intermediate proteins are secreted by immune cells to regulate the function of other immune cells. In addition to inflammatory cells and immune cells that secrete cytokines, there are also growth factors, chemokines, oncogenes, factors [4] [5] [6] involved in growth differentiation and viability.
Cytokines, moreover, are divided into six groups, namely interleukin, colony-stimulating factor, interferon, tumor necrosis factor, growth factor, and chemokine. Many types of cytokines can increase when preeclampsia occurs which might be used as a marker in preeclampsia. Interleukin-6 and TNF-α are also known as proinflammatory mediators that are released and then trigger damage to endothelial cells. This hypothesis, therefore, suggests that endothelial dysfunction plays a significant role in the 2, 7, 8 pathogenesis of preeclampsia.
Preeclampsia is also known to be characterized by systemic endothelial cell dysfunction. Several previous types of research even have already indicated that interleukin-6 was considered as a marker holding the key in the circulation which played a role in endothelial cell dysfunction. 
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Indonesian Journal of Clinical Pathology and Medical Laboratory, 2019 March, 25 (2) : 199 -201 Interleukin-6 could also elevate in the proliferation of trophoblasts, invasion, and oxidative stress during preeclampsia. An excessive maternal inflammatory response then results in an abnormal invasion of the 2 trophoblast. Besides, several previous types of research have revealed variations in the levels of cytokines, such as TNF-α and interleukin-6, in preeclamptic females although the role of pathogenesis and expression in disease is still controversial. Hence, this research aimed to examine the relationship between interleukin-6 and TNF-α in the preeclampsia and control groups using an independent t-test. The results of independent t-test found that there was a significant difference between interleukin-6 and TNF-α in both of the preeclampsia and control groups with a p-value of 0.001. Similarly, research conducted by Afshari et al. also argued that interleukin-6 levels were significantly higher in pregnant females with preeclampsia than in normal ones. However, this research did not find any significant changes in TNF-α concentrations in preeclampticf emales compared to normal pregnant 9 females.
Another previous study conducted by Casart also noticed an increase in interleukin-6 levels in preeclampsia, but it could not be associated with 10 hCG or IL-1β. Like those previous researches, a research conducted by Roudsari et al. study revealed an increase in mean TNF-α level in maternal plasma of pregnant patients with severe preeclampsia compared to those with mild preeclampsia and 4 normal condition. Nevertheless, the increase in TNF-α concentration did not reach statistical significance. Similarly, study conducted by Raghupathy explained that there was an increase in plasma levels of interleukin-6 and IL-8 in amniotic fluid from pregnant patients with preeclampsia. Thus, increased levels of interleukin-6 could be 11 associated with the onset of preeclampsia.
CONCLUSION AND SUGGESTION
In conclusion, there was a significant increase in levels of Interleukin-6 and TNF-α in pregnant females with preeclampsia compared to normal ones with a p-value of 0.001.
Further research should be done by combining a view mediator inflammation parameter, hopefully, interleukin-6 and TNF α can be additional examinations for early diagnosis of preeclampsia.
